EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies

Supriya Peshin iD, Ehab Takrori iD, Naga Anvesh Kodali iD, Faizan Bashir iD, Sakshi Singal

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Supriya Peshin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Norton Community Hospital, Norton, VA 24273, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: funding contribution from Dr. Sakashi Singal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) remains a formidable malignancy with rising incidence and dismal long-term survival, largely due to late-stage presentation and intrinsic resistance to therapy. Recent advances in the multidisciplinary management of PDAC have reshaped treatment paradigms across disease stages. For localized disease, innovations in surgical techniques and the adoption of neoadjuvant strategies have improved resection rates and survival outcomes. In metastatic settings, multiagent chemotherapy regimens and precision therapies targeting BRCA mutations and rare gene fusions are expanding treatment options. Immunotherapeutic modalities, including checkpoint inhibitors, adoptive cell therapies, and mRNA vaccines, show emerging promise despite PDAC’s traditionally immunosuppressive microenvironment. This review synthesizes the current evidence on established therapies and critically evaluates novel and investigational approaches poised to redefine the therapeutic landscape of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansImmunotherapyTumor MicroenvironmentCombined Modality Therapy

Stichwörter der Autor:innen

chemotherapyimmunotherapymRNA vaccineneoadjuvant therapypancreatic ductal adenocarcinomasurgical resectiontargeted therapy

Autor:innen und Institutionen

  • Department of Internal Medicine, Norton Community Hospital, Norton, VA 24273, USA.
  • College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Department of Surgery, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
  • School of Medicine, Shiraz University of Medical Sciences, Shiraz 71348-45794, Iran.
  • Department of Hematology & Oncology, East Tennessee State University, Johnson City, TN 37614, USA.

ORCID-Profile: Supriya Peshin, Ehab Takrori, Naga Anvesh Kodali, Faizan Bashir

Förderung

  • funding contribution from Dr. Sakashi Singal

Zitieren

APA

Peshin, S., Takrori, E., Kodali, N. A., Bashir, F., & Singal, S. (2025). Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157055

Vancouver

Peshin S, Takrori E, Kodali NA, Bashir F, Singal S. Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157055

BibTeX
@article{Peshin2025,
  author = {Peshin, Supriya and Takrori, Ehab and Kodali, Naga Anvesh and Bashir, Faizan and Singal, Sakshi},
  title = {Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157055}
}
Kostenlos starten →